drug

Zolodine

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Second Affiliated Hospital, School of Medicine, Zhejiang University
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)
SchizophreniaSchizophrenia

Trials

1
A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine
NCT04975035Phase 1, Phase 2Terminated

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Second Affiliated Hospital, School of Medicine, Zhejiang University
company
trial
A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine
PHASE1, PHASE2
trial
indication
Schizophrenia
indication
Schizophrenia
indication